e-learning
resources
ERJ
2014
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Inhaled antibiotics: dry or wet?
Tiddens Harm A.W.M., Bos Aukje C., Mouton Johan W., Devadason Sunalene, Janssens Hettie M.
Source:
Eur Respir J 2014; 44: 1308-1318
Journal Issue:
November
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Tiddens Harm A.W.M., Bos Aukje C., Mouton Johan W., Devadason Sunalene, Janssens Hettie M.. Inhaled antibiotics: dry or wet?. Eur Respir J 2014; 44: 1308-1318
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Cystic fibrosis and intestinal organoids
Clinics of Cystic Fibrosis Patients with Unusual Bacteria Isolated fromRespiratory Cultures
Novel therapeutics for cystic fibrosis
Related content which might interest you:
Inhaled antibiotics: a new tool?
Source: Annual Congress 2009 - Antibiotics and the lung
Year: 2009
One-year height growth in children with asthma treated with inhaled budesonide delivered from a new dry powder inhaler.
Source: Annual Congress 2008 - Clinical aspects of asthma in school-aged children
Year: 2008
Difference in resistance to humidity between commonly used dry powder inhalers
Source: International Congress 2015 – New data on established treatments for asthma and COPD
Year: 2015
Do dry powder inhalers (DPIs) have a ‘Goldilocks Zone’ of inhalation? In vitro lung deposition of Budesonide/Formoterol (BUD/FORM) DPI with different inhalation profiles
Source: International Congress 2017 – Pulmonary drug and devices delivery
Year: 2017
Treating acute cough: wet versus dry – have we got the paradigm wrong?
Source: ERJ Open Res 2015; 1: 00055-2015
Year: 2015
Do asthma patients achieve effective dosing from dry powder inhalers (DPIs)?
Source: Eur Respir J 2005; 26: Suppl. 49, 338s
Year: 2005
Steroids in COPD: still up in the air?
Source: Eur Respir J 2010; 35: 949-951
Year: 2010
Systemic availability (lung deposition) of drug from two different dry powder inhalers in children with asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 429s
Year: 2002
Inhaled therapies: can they breathe new life into asthma?
Source: International Congress 2019 – The journey towards personalized medicine in asthma: where are we now?
Year: 2019
Use of dry powder inhalers in COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 286s
Year: 2005
In vitro evaluation of the Twincer colistin dry powder inhaler as a non-cough-inducing alternative to Colobreathe
Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections
Year: 2016
Handling and patient preference of dry powder inhalers for asthma and COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 210s
Year: 2006
Inhaled medication: which device for which patient?
Source: Eur Respir Monogr 2015; 69: 213-223
Year: 2015
Comparison of two dry powder inhalers containing budesonide in the treatment of asthma in children
Source: Eur Respir J 2002; 20: Suppl. 38, 500s
Year: 2002
Systemic activity of two different dry powder combinations of inhaled corticosteroids and long-acting β2-agonists in children with asthma assessed by knemometry
Source: Annual Congress 2012 - Assessing and treating childhood asthma and allergy
Year: 2012
Inhaled corticosteroids reduce growth. Or do they?
Source: Eur Respir J 2001; 17: 287-294
Year: 2001
Applicability of dry powder inhalers in children with CF
Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring
Year: 2016
Are extra-fine particles from dry powder inhalers likely to improve lung deposition?
Source: International Congress 2014 – Asthma and COPD devices and treatments
Year: 2014
Inhaled corticosteroids in COPD: the final verdict is…
Source: Eur Respir J, 52 (6) 1801940; 10.1183/13993003.01940-2018
Year: 2018
Use of a new dry powder inhaler to deliver umeclidinium/vilanterol in the treatment of COPD
Source: Annual Congress 2013 –COPD drugs: new findings
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept